DNA & Genetics Lonza’s Synaffix Collaborates with Qurient Therapeutics on Dual-Payload ADC DevelopmentBy adminSeptember 26, 20250 Synaffix, a Lonza company focused on commercializing its clinical-stage platform technology for the development of antibody-drug conjugates (ADCs), entered into…